Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02289950 |
Title | A Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Subjects With Low CA125 Platinum-Sensitive Ovarian Cancer |
Recruitment | Completed |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Morphotek |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | ITA | GBR | ESP | DEU | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Phoenix | Arizona | United States | Details | |||
Los Angeles | California | United States | Details | |||
Orange | California | United States | Details | |||
Roseville | California | United States | Details | |||
Sacramento | California | United States | Details | |||
Aurora | Colorado | United States | Details | |||
Miami | Florida | United States | Details | |||
Miramar | Florida | United States | Details | |||
Orlando | Florida | United States | Details | |||
Sarasota | Florida | United States | Details | |||
Tampa | Florida | United States | Details | |||
Atlanta | Georgia | United States | Details | |||
Augusta | Georgia | United States | Details | |||
Savannah | Georgia | United States | Details | |||
Chicago | Illinois | United States | Details | |||
Lexington | Kentucky | United States | Details | |||
Louisville | Kentucky | United States | Details | |||
Baltimore | Maryland | United States | Details | |||
Boston | Massachusetts | United States | Details | |||
Detroit | Michigan | United States | Details | |||
Minneapolis | Minnesota | United States | Details | |||
Grand Island | Nebraska | United States | Details | |||
New York | New York | United States | Details | |||
Chapel Hill | North Carolina | United States | Details | |||
Charlotte | North Carolina | United States | Details | |||
Winston-Salem | North Carolina | United States | Details | |||
Centerville | Ohio | United States | Details | |||
Cincinnati | Ohio | United States | Details | |||
Cleveland | Ohio | United States | Details | |||
Columbus | Ohio | United States | Details | |||
Chattanooga | Tennessee | United States | Details | |||
Knoxville | Tennessee | United States | Details | |||
Austin | Texas | United States | Details | |||
Annandale | Virginia | United States | Details | |||
Charlottesville | Virginia | United States | Details | |||
Edegem | Antwerpen | Belgium | Details | |||
Brussels | Bruxelles | Belgium | Details | |||
Hasselt | Limburg | Belgium | Details | |||
Gent | Oost-Vlaanderen | Belgium | Details | |||
Leuven | Belgium | Details | ||||
Liege | Belgium | Details | ||||
Ulm | Baden-Württemberg | Germany | Details | |||
Chemnitz | Sachsen | Germany | Details | |||
Berlin | Germany | Details | ||||
Dresden | Germany | Details | ||||
Essen | Germany | Details | ||||
Napoli | Campania | Italy | Details | |||
Roma | Lazio | Italy | Details | |||
Bari | Puglia | Italy | Details | |||
Avellino | Italy | Details | ||||
Bologna | Italy | Details | ||||
Milano | Italy | Details | ||||
Napoli | Italy | Details | ||||
Perugia | Italy | Details | ||||
Chuo-Ku | Japan | Details | ||||
Hidaka-City | Japan | Details | ||||
Kashiwa-City | Japan | Details | ||||
Koto-Ku | Japan | Details | ||||
Kurume-City | Japan | Details | ||||
Matsuyama-City | Japan | Details | ||||
Minato-Ku | Japan | Details | ||||
SuntoGun | Japan | Details | ||||
Palma de Mallorca | Baleares | Spain | Details | |||
Cordoba | Córdoba | Spain | Details | |||
Madrid | Spain | Details | ||||
Sabadell | Spain | Details | ||||
Plymouth | Devon | United Kingdom | Details | |||
London | United Kingdom | Details |
CKB CORE allows for only a limited number of monthly page views for un-registered users. However, registration is free and allows for unlimited browsing of the CKB CORE content.
You have reached the monthly page view limit. For continued free access to CKB CORE, please register below: